📰 Full Story
More than 3.1 million bottles of over‑the‑counter eye drops manufactured by K.C. Pharmaceuticals Inc. of Pomona, California, have been voluntarily recalled in the United States after the Food and Drug Administration said the company could not assure product sterility.
The recall, initiated by the firm on March 3 and formally classified by the FDA as a Class II action on March 31, covers eight product lines sold under various private‑label and store brands, including Dry Eye Relief and Artificial Tears Sterile Lubricant.
Affected retailers and distributors include Walgreens, CVS, Kroger, Rite Aid, H‑E‑B, Dollar General, Publix, military exchanges and Cardinal Health.
Lot numbers, UPCs and expiration dates are published in the FDA enforcement report.
While no illnesses have been confirmed, the agency warned the lack of sterility could pose a risk of temporary or reversible adverse effects; consumers are advised to stop using affected products and return them for refund or disposal and to seek medical attention if they experience eye pain, redness or vision changes.





💬 Commentary